Leidos has been granted a substantial five-year contract worth $105.5 million to offer operational readiness research support services to the Naval Health Research Center. This contract entails providing investigative studies that involve planning, coordinating, designing, and executing experimental protocols. The work under this contract is slated to commence in September of the current year and will continue until September 2030, with operations planned to be carried out in San Diego, California, and Reston, Virginia.
The Department of Defense highlighted that the Naval Supply Systems Command Fleet Logistics Center Norfolk has obligated an initial amount of $1,000 from the fiscal 2025 research, development, test, and evaluation Navy funds towards this contract. Subsequent task orders will be financed using the appropriate fiscal RDT&E Navy funds. The procurement process for this contract was competitive, with Leidos emerging as the successful bidder amongst the contenders.
In a previous contract awarded in 2020, Leidos secured a potential $82.1 million deal to support investigative studies at the Naval Health Research Center’s Operational Readiness Directorate. The scope of work encompassed analysis and reporting support, data monitoring, database framework creation, and the development of operationally relevant research concepts. This new contract solidifies Leidos’ commitment to advancing research in support of naval health and operational readiness.
Key Takeaways:
– Leidos has secured a significant $105.5 million contract to provide operational readiness research support services to the Naval Health Research Center.
– The contract spans five years and involves investigative studies focused on experimental protocols and operational research.
– Leidos won the competitive procurement process against one other bidder, emphasizing the company’s expertise and capabilities in this domain.
– This contract builds upon Leidos’ previous engagement in supporting investigative studies at the Naval Health Research Center, showcasing the company’s continued dedication to advancing naval health research.
Read more on govconwire.com